Financhill
Sell
39

IOSP Quote, Financials, Valuation and Earnings

Last price:
$95.15
Seasonality move :
6.32%
Day range:
$94.77 - $97.36
52-week range:
$94.77 - $133.71
Dividend yield:
1.63%
P/E ratio:
68.00x
P/S ratio:
1.30x
P/B ratio:
1.96x
Volume:
123.6K
Avg. volume:
306.2K
1-year change:
-26.17%
Market cap:
$2.4B
Revenue:
$1.8B
EPS (TTM):
$1.40

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IOSP
Innospec
$447.4M $1.36 -6.54% -12.53% $131.50
ALTO
Alto Ingredients
$222.8M -$0.11 -7.66% -17.65% $4.50
BCPC
Balchem
$240M $1.11 2.52% 36.52% $199.33
FRD
Friedman Industries
-- -- -- -- --
PZG
Paramount Gold Nevada
-- -$0.03 -- -- $1.40
XPL
Solitario Resources
-- -$0.02 -- -- $1.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IOSP
Innospec
$95.20 $131.50 $2.4B 68.00x $0.79 1.63% 1.30x
ALTO
Alto Ingredients
$1.17 $4.50 $89.6M -- $0.00 0% 0.09x
BCPC
Balchem
$163.79 $199.33 $5.3B 41.68x $0.87 0.53% 5.62x
FRD
Friedman Industries
$15.08 -- $105.1M 18.62x $0.04 1.06% 0.23x
PZG
Paramount Gold Nevada
$0.38 $1.40 $25.4M -- $0.00 0% --
XPL
Solitario Resources
$0.60 $1.50 $49M -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IOSP
Innospec
-- 1.651 -- 1.70x
ALTO
Alto Ingredients
29.22% -1.356 77.78% 1.62x
BCPC
Balchem
14.18% 1.260 4.12% 1.07x
FRD
Friedman Industries
20.34% -0.384 30.78% 0.78x
PZG
Paramount Gold Nevada
-- 1.921 -- --
XPL
Solitario Resources
-- -1.152 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IOSP
Innospec
$136.2M $37.4M 2.97% 2.97% 8.01% $4.9M
ALTO
Alto Ingredients
-$1.4M -$6.7M -16.99% -22.63% -16.53% -$11.1M
BCPC
Balchem
$86.3M $47.4M 9.36% 11.53% 19.71% $39.6M
FRD
Friedman Industries
$8.1M -$1.6M 3.41% 4.48% -0.98% $1.6M
PZG
Paramount Gold Nevada
-$186.4K -$1.2M -- -- -- -$946.4K
XPL
Solitario Resources
-$6K -$1.6M -- -- -- -$1.7M

Innospec vs. Competitors

  • Which has Higher Returns IOSP or ALTO?

    Alto Ingredients has a net margin of -15.08% compared to Innospec's net margin of -17.65%. Innospec's return on equity of 2.97% beat Alto Ingredients's return on equity of -22.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    ALTO
    Alto Ingredients
    -0.59% -$0.57 $318M
  • What do Analysts Say About IOSP or ALTO?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 38.13%. On the other hand Alto Ingredients has an analysts' consensus of $4.50 which suggests that it could grow by 284.62%. Given that Alto Ingredients has higher upside potential than Innospec, analysts believe Alto Ingredients is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    ALTO
    Alto Ingredients
    1 0 0
  • Is IOSP or ALTO More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Alto Ingredients has a beta of 1.735, suggesting its more volatile than the S&P 500 by 73.514%.

  • Which is a Better Dividend Stock IOSP or ALTO?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.63%. Alto Ingredients offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 108.99% of its earnings as a dividend. Alto Ingredients pays out -2.15% of its earnings as a dividend.

  • Which has Better Financial Ratios IOSP or ALTO?

    Innospec quarterly revenues are $466.8M, which are larger than Alto Ingredients quarterly revenues of $236.3M. Innospec's net income of -$70.4M is lower than Alto Ingredients's net income of -$41.7M. Notably, Innospec's price-to-earnings ratio is 68.00x while Alto Ingredients's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.30x versus 0.09x for Alto Ingredients. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.30x 68.00x $466.8M -$70.4M
    ALTO
    Alto Ingredients
    0.09x -- $236.3M -$41.7M
  • Which has Higher Returns IOSP or BCPC?

    Balchem has a net margin of -15.08% compared to Innospec's net margin of 13.99%. Innospec's return on equity of 2.97% beat Balchem's return on equity of 11.53%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    BCPC
    Balchem
    35.97% $1.03 $1.3B
  • What do Analysts Say About IOSP or BCPC?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 38.13%. On the other hand Balchem has an analysts' consensus of $199.33 which suggests that it could grow by 21.7%. Given that Innospec has higher upside potential than Balchem, analysts believe Innospec is more attractive than Balchem.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    BCPC
    Balchem
    0 0 0
  • Is IOSP or BCPC More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Balchem has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.287%.

  • Which is a Better Dividend Stock IOSP or BCPC?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.63%. Balchem offers a yield of 0.53% to investors and pays a quarterly dividend of $0.87 per share. Innospec pays 108.99% of its earnings as a dividend. Balchem pays out 19.91% of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec's is not.

  • Which has Better Financial Ratios IOSP or BCPC?

    Innospec quarterly revenues are $466.8M, which are larger than Balchem quarterly revenues of $240M. Innospec's net income of -$70.4M is lower than Balchem's net income of $33.6M. Notably, Innospec's price-to-earnings ratio is 68.00x while Balchem's PE ratio is 41.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.30x versus 5.62x for Balchem. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.30x 68.00x $466.8M -$70.4M
    BCPC
    Balchem
    5.62x 41.68x $240M $33.6M
  • Which has Higher Returns IOSP or FRD?

    Friedman Industries has a net margin of -15.08% compared to Innospec's net margin of -1.23%. Innospec's return on equity of 2.97% beat Friedman Industries's return on equity of 4.48%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    FRD
    Friedman Industries
    8.6% -$0.17 $159.8M
  • What do Analysts Say About IOSP or FRD?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 38.13%. On the other hand Friedman Industries has an analysts' consensus of -- which suggests that it could fall by --. Given that Innospec has higher upside potential than Friedman Industries, analysts believe Innospec is more attractive than Friedman Industries.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    FRD
    Friedman Industries
    0 0 0
  • Is IOSP or FRD More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Friedman Industries has a beta of 1.417, suggesting its more volatile than the S&P 500 by 41.675%.

  • Which is a Better Dividend Stock IOSP or FRD?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.63%. Friedman Industries offers a yield of 1.06% to investors and pays a quarterly dividend of $0.04 per share. Innospec pays 108.99% of its earnings as a dividend. Friedman Industries pays out 3.35% of its earnings as a dividend. Friedman Industries's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec's is not.

  • Which has Better Financial Ratios IOSP or FRD?

    Innospec quarterly revenues are $466.8M, which are larger than Friedman Industries quarterly revenues of $94.1M. Innospec's net income of -$70.4M is lower than Friedman Industries's net income of -$1.2M. Notably, Innospec's price-to-earnings ratio is 68.00x while Friedman Industries's PE ratio is 18.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.30x versus 0.23x for Friedman Industries. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.30x 68.00x $466.8M -$70.4M
    FRD
    Friedman Industries
    0.23x 18.62x $94.1M -$1.2M
  • Which has Higher Returns IOSP or PZG?

    Paramount Gold Nevada has a net margin of -15.08% compared to Innospec's net margin of --. Innospec's return on equity of 2.97% beat Paramount Gold Nevada's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    PZG
    Paramount Gold Nevada
    -- -$0.03 --
  • What do Analysts Say About IOSP or PZG?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 38.13%. On the other hand Paramount Gold Nevada has an analysts' consensus of $1.40 which suggests that it could grow by 272.34%. Given that Paramount Gold Nevada has higher upside potential than Innospec, analysts believe Paramount Gold Nevada is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    PZG
    Paramount Gold Nevada
    1 0 0
  • Is IOSP or PZG More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Paramount Gold Nevada has a beta of 1.923, suggesting its more volatile than the S&P 500 by 92.323%.

  • Which is a Better Dividend Stock IOSP or PZG?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.63%. Paramount Gold Nevada offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 108.99% of its earnings as a dividend. Paramount Gold Nevada pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IOSP or PZG?

    Innospec quarterly revenues are $466.8M, which are larger than Paramount Gold Nevada quarterly revenues of --. Innospec's net income of -$70.4M is lower than Paramount Gold Nevada's net income of -$2M. Notably, Innospec's price-to-earnings ratio is 68.00x while Paramount Gold Nevada's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.30x versus -- for Paramount Gold Nevada. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.30x 68.00x $466.8M -$70.4M
    PZG
    Paramount Gold Nevada
    -- -- -- -$2M
  • Which has Higher Returns IOSP or XPL?

    Solitario Resources has a net margin of -15.08% compared to Innospec's net margin of --. Innospec's return on equity of 2.97% beat Solitario Resources's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    XPL
    Solitario Resources
    -- -$0.02 --
  • What do Analysts Say About IOSP or XPL?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 38.13%. On the other hand Solitario Resources has an analysts' consensus of $1.50 which suggests that it could grow by 149.92%. Given that Solitario Resources has higher upside potential than Innospec, analysts believe Solitario Resources is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    XPL
    Solitario Resources
    0 0 0
  • Is IOSP or XPL More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Solitario Resources has a beta of 0.921, suggesting its less volatile than the S&P 500 by 7.928%.

  • Which is a Better Dividend Stock IOSP or XPL?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.63%. Solitario Resources offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 108.99% of its earnings as a dividend. Solitario Resources pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IOSP or XPL?

    Innospec quarterly revenues are $466.8M, which are larger than Solitario Resources quarterly revenues of --. Innospec's net income of -$70.4M is lower than Solitario Resources's net income of -$1.6M. Notably, Innospec's price-to-earnings ratio is 68.00x while Solitario Resources's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.30x versus -- for Solitario Resources. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.30x 68.00x $466.8M -$70.4M
    XPL
    Solitario Resources
    -- -- -- -$1.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will SoundHound AI Stock Recover?
Will SoundHound AI Stock Recover?

SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…

What Stocks Did Warren Buffett Just Buy?
What Stocks Did Warren Buffett Just Buy?

In Q4 of last year, Warren Buffett added to or…

Is it Finally Time to Buy Medical Properties Trust?
Is it Finally Time to Buy Medical Properties Trust?

Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

Sell
24
AIR alert for Mar 29

AAR [AIR] is down 16.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock